{"id":10859,"date":"2022-11-04T11:41:06","date_gmt":"2022-11-04T11:41:06","guid":{"rendered":"https:\/\/www.tender-lederberg.94-130-216-58.plesk.page\/292-2\/"},"modified":"2024-12-18T13:50:45","modified_gmt":"2024-12-18T13:50:45","slug":"292-2","status":"publish","type":"post","link":"https:\/\/www.af-net.eu\/en\/292-2\/","title":{"rendered":"AXADIA-AFNET8 and EAST-AFNET4 @ AHA Congress 2022"},"content":{"rendered":"\n<div class=\"header-small-aktuelles\">\n        <div class=\"header-small-headline\">\n            <h5>Posts<\/h5><h1> <strong>NEWS<\/strong><\/h1>\n        <\/div>\n    <\/div>\n\n\n\n<div style=\"height:50px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<p>Fri, 04.11.2022<\/p>\n\n\n\n<h3 class=\"wp-block-heading has-afnet-blau-color has-text-color has-link-color wp-elements-f1b16c7fea90246a0c18902ffecddb7a\">AXADIA-AFNET8 and EAST-AFNET4 @ AHA Congress 2022<\/h3>\n\n\n\n<p>The results of the AXADIA-AFNET8 trial and another EAST-AFNET4 subanalysis&nbsp;will be presented at this year&#8217;s AHA congress (Chicago, US) :<\/p>\n\n\n\n<p>Featured Science Session (<em>FS.03)<\/em><em>:<\/em>\u00a0Featured Science in Heart Rhythm Medicine<br><strong>A<\/strong><strong>pixaban or vitamin K antagonists for stroke prevention in patients with atrial fibrillation on hemodialysis: Results of the randomized AXADIA-AFNET 8 trial<\/strong><br>Monday, 7th of November 2022\u00a0| 0:20 \u2013 0:30\u00a0(CET) \/ Sunday, 6th of November 2022\u00a0| 5:20pm\u00a0\u2013 5:30pm (CST)<br>Speaker:\u00a0Dr. Paulus Kirchhof<br><a href=\"https:\/\/professional.heart.org\/en\/meetings\/scientific-sessions\/programming\/late-breaking-science\" target=\"_blank\" rel=\"noreferrer noopener\">More information<\/a><\/p>\n\n\n\n<p>Featured Science Session (<em>FS.03)<\/em><em>:<\/em>\u00a0Featured Science in Heart Rhythm Medicine<br><strong>Association of genetic risk and outcomes in patients with early rhythm control therapy in atrial fibrillation: Results from the EAST-AFNET4\u00a0trial<\/strong><br>Monday, 7th of November 2022\u00a0| 0:30 \u2013 0:40\u00a0(CET) \/ Sunday, 6th of November 2022\u00a0| 5:30pm\u00a0\u2013 5:40pm (CST)<br>Speaker:\u00a0Dr. Shinwan Kany<br><a href=\"https:\/\/professional.heart.org\/en\/meetings\/scientific-sessions\/programming\/late-breaking-science\" target=\"_blank\" rel=\"noreferrer noopener\">More information<\/a><\/p>\n\n\n\n<p><\/p>\n","protected":false},"excerpt":{"rendered":"<p>The results of the AXADIA-AFNET8 trial and another EAST-AFNET4 subanalysis\u00a0will be presented at this year&#8217;s AHA congress (Chicago, US) :<\/p>\n<p>Featured Science Session (FS.03):\u00a0Featured Science in Heart Rhythm Medicine<br \/>\nApixaban or vitamin K antagonists for stroke prevention in patients with atrial fibrillation on hemodialysis: Results of the randomized AXADIA-AFNET 8 trial<br \/>\nMonday, 7th of November 2022\u00a0| 0:20 \u2013 0:30\u00a0(CET) \/ Sunday, 6th of November 2022\u00a0| 5:20pm\u00a0\u2013 5:30pm (CST)<br \/>\nSpeaker:\u00a0Dr. Paulus Kirchhof<br \/>\nMore information<\/p>\n","protected":false},"author":1,"featured_media":11961,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_uag_custom_page_level_css":"","iawp_total_views":7,"_vp_format_video_url":"","_vp_image_focal_point":[],"footnotes":""},"categories":[21,19,1],"tags":[],"class_list":["post-10859","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news-en","category-news-2","category-unkategorisiert"],"acf":[],"uagb_featured_image_src":{"full":["https:\/\/www.af-net.eu\/wp-content\/uploads\/2022\/11\/2023_November_4-1.png",398,164,false],"thumbnail":["https:\/\/www.af-net.eu\/wp-content\/uploads\/2022\/11\/2023_November_4-1-150x150.png",150,150,true],"medium":["https:\/\/www.af-net.eu\/wp-content\/uploads\/2022\/11\/2023_November_4-1-300x124.png",300,124,true],"medium_large":["https:\/\/www.af-net.eu\/wp-content\/uploads\/2022\/11\/2023_November_4-1.png",398,164,false],"large":["https:\/\/www.af-net.eu\/wp-content\/uploads\/2022\/11\/2023_November_4-1.png",398,164,false],"timeline-express":["https:\/\/www.af-net.eu\/wp-content\/uploads\/2022\/11\/2023_November_4-1-350x120.png",350,120,true],"timeline-express-thumbnail":["https:\/\/www.af-net.eu\/wp-content\/uploads\/2022\/11\/2023_November_4-1-200x120.png",200,120,true],"1536x1536":["https:\/\/www.af-net.eu\/wp-content\/uploads\/2022\/11\/2023_November_4-1.png",398,164,false],"2048x2048":["https:\/\/www.af-net.eu\/wp-content\/uploads\/2022\/11\/2023_November_4-1.png",398,164,false],"vp_sm":["https:\/\/www.af-net.eu\/wp-content\/uploads\/2022\/11\/2023_November_4-1.png",398,164,false],"vp_md":["https:\/\/www.af-net.eu\/wp-content\/uploads\/2022\/11\/2023_November_4-1.png",398,164,false],"vp_lg":["https:\/\/www.af-net.eu\/wp-content\/uploads\/2022\/11\/2023_November_4-1.png",398,164,false],"vp_xl":["https:\/\/www.af-net.eu\/wp-content\/uploads\/2022\/11\/2023_November_4-1.png",398,164,false],"vp_sm_popup":["https:\/\/www.af-net.eu\/wp-content\/uploads\/2022\/11\/2023_November_4-1.png",398,164,false],"vp_md_popup":["https:\/\/www.af-net.eu\/wp-content\/uploads\/2022\/11\/2023_November_4-1.png",398,164,false],"vp_xl_popup":["https:\/\/www.af-net.eu\/wp-content\/uploads\/2022\/11\/2023_November_4-1.png",398,164,false]},"uagb_author_info":{"display_name":"admin","author_link":"https:\/\/www.af-net.eu\/en\/author\/cre8ors\/"},"uagb_comment_info":0,"uagb_excerpt":"The results of the AXADIA-AFNET8 trial and another EAST-AFNET4 subanalysis\u00a0will be presented at this year's AHA congress (Chicago, US) : Featured Science Session (FS.03):\u00a0Featured Science in Heart Rhythm Medicine Apixaban or vitamin K antagonists for stroke prevention in patients with atrial fibrillation on hemodialysis: Results of the randomized AXADIA-AFNET 8 trial Monday, 7th of November&hellip;","_links":{"self":[{"href":"https:\/\/www.af-net.eu\/en\/wp-json\/wp\/v2\/posts\/10859","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.af-net.eu\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.af-net.eu\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.af-net.eu\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.af-net.eu\/en\/wp-json\/wp\/v2\/comments?post=10859"}],"version-history":[{"count":3,"href":"https:\/\/www.af-net.eu\/en\/wp-json\/wp\/v2\/posts\/10859\/revisions"}],"predecessor-version":[{"id":13416,"href":"https:\/\/www.af-net.eu\/en\/wp-json\/wp\/v2\/posts\/10859\/revisions\/13416"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.af-net.eu\/en\/wp-json\/wp\/v2\/media\/11961"}],"wp:attachment":[{"href":"https:\/\/www.af-net.eu\/en\/wp-json\/wp\/v2\/media?parent=10859"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.af-net.eu\/en\/wp-json\/wp\/v2\/categories?post=10859"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.af-net.eu\/en\/wp-json\/wp\/v2\/tags?post=10859"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}